Skip to main content
. Author manuscript; available in PMC: 2014 Apr 3.
Published in final edited form as: Am J Nephrol. 2013 Apr 3;37(5):10.1159/000349930. doi: 10.1159/000349930

Table 1. Demographic and baseline parameters.

Variables Metabolic Syndrome p

Yes (34) No (40)
Age, years (SD) 47.5 (13.9) 44.1 (15.0) 0.32
Gender male, n (%) 24 (70.6) 26 (65.0) 0.61
Race AA, n (%) 9 (26.4) 13 (32.5) 0.57
BMI, kg/m2 (SD) 29.5 (5.7) 26.2 (4.8) 0.01
Living donor transplant, n (%) 13 (38.2) 24 (60.0) 0.06
First transplant, n (%) 29 (85.3) 36 (90.0) 0.72
Positive HCV serology, n (%) 3 (8.8) 3 (7.5) 1.00
Family history for T2D, n (%) 10 (29.4) 7 (17.5) 0.22
Smoking history, n (%) 0.89
 Never 21 (61.8) 24 (60.0)
 Former 10 (29.4) 11 (27.5)
 Current 3 (8.8) 5 (12.5)
Renal diagnosis, n (%) 0.49
 APKD 5 (15.2) 5 (12.5)
 Glomerular disease 17 (51.5) 14 (35.0)
 Hypertension 6 (17.7) 9 (22.5)
 Others 6 (18.2) 12 (30.0)
Dialysis modalities, n (%) 0.65
 None 7 (20.6) 12 (30.0)
 HD 5 (14.7) 5 (12.5)
 PD 22 (64.7) 23 (57.5)
Dialysis duration, years (SD) 3.9 (3.0) 2.9 (2.5) 0.17
Fasting glucose at transplant, mg/dl (SD) 86.2 (9.0) 84.6 (8.7) 0.46
CNIs: CsA, n (%) 30 (88.3) 33 (82.5) 0.64
Cumulative CNI doses, mg (SD)
 CsA 41221 (13665) 35513 (11142) 0.07
 Tacro 753 (64) 436 (66) 0.06
Cumulative prednisone doses, mg (SD) 2521 (466) 2428 (286) 0.30
Delayed graft function, n (%) 5 (14.7) 5 (12.5) 0.78